Skip to main content
Filing year 2024

PATIENTS FOR AFFORDABLE DRUGS

Washington, District of Columbia·EIN 81-4011501·NTEE E01 · Health Care·501(c)(3)
Total revenue
$2.6M
Total assets
$2.1M
Total expenses
$2M
Reported officers
9
Mission

THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS.

Executive compensation, broken down

Form 990 · Part VII & Schedule J · 5 reported individuals · Filing year 2024

Percentile bands compare each position's total pay with the same role at Health Care organizations nationwide.

Executive Director
Median to 75th percentilevs Health Care peers in District of Columbia
$246k
$261k
Base
$237k
Bonus
Other
Benefits
$9k
Chief Operating Officer
Median to 75th percentile
$219k
$233k
Base
$196k
Bonus
Other
Benefits
$23k
Community Organizing and Advocacy Director
Highest Compensated Employee
10th to 25th percentilevs Health Care peers in District of Columbia
$135k
$143k
Director of Media and Communications
Director (Operational)
Median to 75th percentile
$125k
$132k
Director of Legislation, Policy and Alliances
Director (Operational)
10th to 25th percentile
$44k
$47k

Teal figures restate each filed amount in 2026 dollars.

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Plus 4 unpaid individuals.

Browse compensation in Health Care

Pay in context

Top pay as a share of expenses

In 2024, the highest total compensation at PATIENTS FOR AFFORDABLE DRUGS equaled 12% of the organization's total expenses. The median for health care organizations is 4%.

This organization (2024)
12%
Sector median
4%
Middle half of sector
1% to 13%

Based on 13,830 health care organizations, each measured at its most recent filing year with reported expenses and compensation.

Funded by

Private foundations whose Form 990-PF Part XV grants matched this organization.

Climbed 32%
over 2 years

From $187k in 2022 to $246k in 2024.

$187k
2022
$233k
2023
$246k
2024
In today's dollarsEst.
Up 24% in real terms$211k to $261k

Estimated with Washington-Arlington-Alexandria, DC-VA-MD-WV metro-area CPI-U, restating filed pay into May 2026 dollars. A restatement of past pay, not current or projected pay.

Pay for the position

Chief Executive Officer pay rose 229% from 2022 to 2024, while revenue rose 30%.

$75k in 2022 to $246k in 2024.
  • Chief Operating Officer pay rose 17% from 2022 to 2024.
  • Director (Operational) pay fell 29% from 2022 to 2024.

Pay for the position itself, not any one person. The officeholder may have changed between 2022 and 2024.

Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

FAQ

Common questions about PATIENTS FOR AFFORDABLE DRUGS

What does the Chief Executive Officer of PATIENTS FOR AFFORDABLE DRUGS earn?

In 2024, the Chief Executive Officer of PATIENTS FOR AFFORDABLE DRUGS received $246,091 in total compensation. This pay is above the median (the midpoint) for Chief Executive Officer roles among Health Care organizations in District of Columbia, within the top half of comparable filings. Based on IRS Form 990 data.

How does Chief Executive Officer pay at PATIENTS FOR AFFORDABLE DRUGS compare with similar nonprofits?

Compared with the same role at Health Care organizations in District of Columbia, the 2024 pay of the Chief Executive Officer at PATIENTS FOR AFFORDABLE DRUGS falls between the median and the 75th percentile. In 2024, the highest total compensation at PATIENTS FOR AFFORDABLE DRUGS equaled 12% of the organization's total expenses. The median for health care organizations is 4%.

What are PATIENTS FOR AFFORDABLE DRUGS's revenue and expenses?

In 2024, PATIENTS FOR AFFORDABLE DRUGS reported $2.6M in total revenue and $2M in total expenses on its IRS Form 990.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.